Lobbyists say Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023 in the absence of a major court decision.

340B Lobbying Activity Experiences Historic Surge

August 15, 2023 Rich Daly Editor in Chief Views

The hiring of lobbyists in the congressional legislative fight over 340B was dominated by pharmaceutical firms and provider-manufacturer alliances in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

340B Lobbying Activity Experiences Historic Surge

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

If you are not yet a paid subscriber, please Subscribe now.

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

Rich Daly